0
0
Home » Medical Devices » Ophthalmic Devices

Glaucoma Surgery Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

Glaucoma Surgery Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Ophthalmic Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Glaucoma Surgery Devices market for the year 2020 and beyond. Aging population coupled with increase in incidence and prevalence of glaucoma globally is the leading cause of irreversible vision loss, and best preventive measure to stop the irreversible vision loss is drainage of fluids from the eyes. This is expected to increase sales of valved and non-valved drainage devices.

Glaucoma Surgery Devices have a long history of use in the US and European markets and are well established in emerging markets such as APAC and South America.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are –

Currently marketed Glaucoma Surgery Devices and evolving competitive landscape –

  • Insightful review of the key industry trends.
  • Annualized total Glaucoma Surgery Devices market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights –

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Glaucoma Surgery Devices market.
  • Competitive dynamics insights and trends provided for Venous Stents market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Glaukos Corp, AbbVie Inc, Alcon Inc, Johnson & Johnson, New World Medical, Incorporated, Aurolab, Ivantis Inc, Santen Pharmaceutical Co Ltd, Nova Eye Medical Ltd, Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope of the Glaucoma Surgery Devices market model

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Currently marketed Glaucoma Surgery Devices and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total glaucoma surgery devices market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.
  • Global, Regional and Country level market specific insights include qualitative market specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for glaucoma surgery devices market.
  • Competitive dynamics insights and trends provided for glaucoma surgery devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

What is the Glaucoma Surgery Devices market size during the historical and forecast period?

Glaucoma Surgery Devices market, by segment

Glaucoma Surgery Devices market, by segment

For more segment insights, download a free report sample

What are the key trends within the Glaucoma Surgery Devices market?

North America holds the largest market for glaucoma surgery devices and GlobalData expects this region to experience fast growth of glaucoma drainage devices market in the forecast period.

Europe has the third largest market for glaucoma surgery devices. The market has a highly variable penetration in Europe, mostly due to highly variable reimbursement systems. In most of the European countries, the usage of valved drainage devices is higher as compared to non-valved drainage device and MIGS devices. The growth rates are expected to follow the country’s growth trends of glaucoma drainage devices.

Asia-Pacific has the second largest market for glaucoma surgery devices. GlobalData expects this region to showcast a similar trend in forecasting years as well. It is also one of the fastest growing market due to aging population and growing demand to address unmet needs in the population. Developed countries such as Australia and New Zealand follow similar trends to North America due to their economic and healthcare infrastructure. Japan and South Korea are the emerging markets, with increasing ageing population which contributes to the higher growth in glaucoma drainage devices market. Less developed countries such as India, have small markets due to a lack of education and infrastructure in healthcare. The region has an increasing trend of government-driven price management and reimbursement controls, particularly in China and Japan.

Due to improving healthcare infrastructures and widening of distribution networks, the market is expected to grow steadily in South & Central America. Weakening currencies in some countries have impacted the budgets of the public healthcare systems.

Increasing investments in the healthcare infrastructure Middle East & Africa will drive the market in the forecast period, along with a growing ageing population, improvements in life expectancy, and increased awareness among both patients and physicians regarding available treatment options. Certain countries in the Middle East have some of the most advanced facilities in the world but the advanced facilities are located in large, urban centers, limiting accessibility for rural populations.

Glaucoma Surgery Devices market report scope

Market value (Year – 2021) $369.8 million
Segmentation by sector Glaucoma Drainage Devices and Minimally Invasive Glucoma Surgery Devices
Key companies Glaukos Corp, AbbVie Inc, Alcon Inc, Johnson & Johnson, New World Medical, Incorporated, Aurolab, Ivantis Inc, Santen Pharmaceutical Co Ltd, Nova Eye Medical Ltd, Others.
Regions covered North America, South & Central America, Europe, Middle East & Africa, Asia-Pacific
Countries covered United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile

Who are the Glaucoma Surgery Devices market vendors?

The model analyses the competitive landscape of the glaucoma surgery devices market and includes information on the following key market vendors:

Glaukos Corp, AbbVie Inc, Alcon Inc, Johnson & Johnson, New World Medical, Incorporated, Aurolab, Ivantis Inc, Santen Pharmaceutical Co Ltd, Nova Eye Medical Ltd, Others.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –

– CMO executives who must have deep understanding of the Glaucoma Surgery Devices marketplace to make strategic planning and investment decisions.

– Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.

– Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to –

– Understand the impact of COVID-19 on Glaucoma Surgery Devices.

– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

– Develop business strategies by understanding the trends shaping and driving Glaucoma Surgery Devices.

– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Glaucoma Surgery Devices market in the future.

– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.

– Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.

– Track device sales in the global and country-specific Glaucoma Surgery Devices market from 2015-2030.

– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Key Players

Glaukos Corp

AbbVie Inc

Alcon Inc

Johnson & Johnson

New World Medical, Incorporated

Aurolab

Ivantis Inc

Santen Pharmaceutical Co Ltd

Nova Eye Medical Ltd

Others

Frequently Asked Questions

The Glaucoma Surgery Devices market was valued at $369.8 million in 2021.

The glaucoma surgery devices market has been segmented by product (Glaucoma Drainage Devices and Minimally Invasive Glucoma Surgery Devices), 5 regions (North America, South & Central America, Europe, Middle East & Africa and Asia-Pacific) and 39 countries.

Key players in the Glaucoma Surgery Devices market include Glaukos Corp, AbbVie Inc, Alcon Inc, Johnson & Johnson, New World Medical, Incorporated, Aurolab, Ivantis Inc, Santen Pharmaceutical Co Ltd, Nova Eye Medical Ltd, Others.

Glaucoma Drainage Devices has the largest share of the global glaucoma surgery devices market.

Glaukos Corp has the largest market share in the glaucoma surgery devices market.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports